Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDViemed Healthcare, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.07 | $0.07 | $0.07 |
| Q2 2024 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2024 | 1 | $0.07 | $0.08 | $0.08 |
| Q4 2024 | 1 | $0.10 | $0.11 | $0.11 |
| Q1 2025 | 1 | $0.10 | $0.10 | $0.10 |
| Q2 2025 | 1 | $0.10 | $0.10 | $0.10 |
| Q3 2025 | 1 | $0.11 | $0.11 | $0.11 |
Viemed Healthcare, Inc. Earnings Date And Information
Viemed Healthcare, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $0.1 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. The company had revenue of 58.00 M for the quarter and had revenue of 183.01 M for the year. Viemed Healthcare, Inc. has generated $0 earnings per share over the last year ($0.25 diluted earnings per share) and currently has a price-to-earnings ratio of 29.83. Viemed Healthcare, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Viemed Healthcare, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | $0.08 | $0.10 | 0.02 | $57.15 M | $58.00 M |
| 08/07/2024 | Q2 2024 | $0.07 | $0.04 | -0.03 | $53.80 M | $54.97 M |
| 05/06/2024 | Q1 2024 | $0.07 | $0.04 | -0.03 | $50.59 M | |
| 03/06/2024 | Q4 2023 | $0.10 | $0.09 | -0.01 | $52.14 M | |
| 11/01/2023 | Q3 2023 | $0.09 | $0.08 | -0.02 | $49.50 M | $49.40 M |
| 08/09/2023 | Q2 2023 | $0.05 | $0.06 | 0.01 | $41.55 M | $43.31 M |
| 05/08/2023 | Q1 2023 | $0.04 | $0.04 | -0 | $39.56 M | |
| 03/02/2023 | Q4 2022 | $0.04 | $0.06 | 0.02 | $37.51 M | |
| 11/01/2022 | Q3 2022 | $0.05 | $0.03 | -0.02 | $34.80 M | $35.76 M |
| 08/02/2022 | Q2 2022 | $0.07 | $0.02 | -0.05 | $32.30 M | $33.31 M |
| 05/03/2022 | Q1 2022 | $0.05 | $0.04 | -0.01 | $32.26 M | |
| 03/07/2022 | Q4 2021 | $0.06 | $0.10 | 0.04 | $31.96 M | |
| 11/01/2021 | Q3 2021 | $0.05 | $27.74 M | $29.29 M | ||
| 08/02/2021 | Q2 2021 | $0.04 | $27.25 M | $27.40 M | ||
| 05/03/2021 | Q1 2021 | $0.06 | $0.04 | -0.02 | $28.42 M | |
| 03/03/2021 | Q4 2020 | $0.03 | $0.13 | 0.1 | $31.20 M | |
| 11/04/2020 | Q3 2020 | $0.08 | $0.07 | -0.01 | $31.69 M | $33.45 M |
| 08/04/2020 | Q2 2020 | $0.50 | $36.68 M | $42.85 M | ||
| 05/04/2020 | Q1 2020 | $0.11 | $23.81 M | |||
| 03/03/2020 | Q4 2019 | $0.06 | $21.45 M |
Viemed Healthcare, Inc. Earnings: FAQ's
When is Viemed Healthcare, Inc.'s earnings date?
Viemed Healthcare, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
Did Viemed Healthcare, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Viemed Healthcare, Inc. (:VMD) reported $0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $0.08 by $0.02.
How can I listen to Viemed Healthcare, Inc.'s earnings conference
call?
The conference call for Viemed Healthcare, Inc.'s latest earnings report can be listened to online.
How can I read Viemed Healthcare, Inc.'s conference call transcript?
The conference call transcript for Viemed Healthcare, Inc.'s latest earnings report can be read online.
How much revenue does Viemed Healthcare, Inc. generate each year?
Viemed Healthcare, Inc. (:VMD) has a recorded annual revenue of $183.01 M.
How much profit does Viemed Healthcare, Inc. generate each year?
Viemed Healthcare, Inc. (:VMD) has a recorded net income of $183.01 M. Viemed Healthcare, Inc. has generated $0.27 earnings per share over the last four quarters.
What is Viemed Healthcare, Inc.'s price-to-earnings ratio?
Viemed Healthcare, Inc. (:VMD) has a price-to-earnings ratio of 29.83 and price/earnings-to-growth ratio is 3.73.